FDA
approval
· 2026-01-30
FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
Summary
FDA approves Alembic Pharmaceuticals Limited's supplemental application for a lamotrigine chewable dispersible formulation, adding this dosage form to the avail…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMOTRIGINE (LAMOTRIGINE CHEWABLE DISPERSIBLE)